ACE-话题@MedSci

#ACE#

496篇内容 | 2916人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1655971, encodeId=ae0e16559e11e, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, objectType=article, longId=179627, objectId=a28c1e962734, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a28c1e962734, replyNumber=0, likeNumber=78, createdTime=2020-04-23, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a28c1e962734, moduleTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a28c1e962734)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656012, encodeId=ba60165601234, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Pharmaceutics：西地那非体外溶解动力学揭示以用于新制剂的开发, objectType=article, longId=192979, objectId=da761929e91a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da761929e91a, replyNumber=0, likeNumber=69, createdTime=2020-06-24, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da761929e91a, moduleTitle=Pharmaceutics：西地那非体外溶解动力学揭示以用于新制剂的开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da761929e91a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655985, encodeId=f5b71655985c5, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=滕皋军教授：肝癌综合治疗新时代--TACE与系统治疗“强强联合”, objectType=article, longId=184914, objectId=d61c1849143f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d61c1849143f, replyNumber=0, likeNumber=78, createdTime=2020-02-16, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d61c1849143f, moduleTitle=滕皋军教授：肝癌综合治疗新时代--TACE与系统治疗“强强联合”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d61c1849143f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655972, encodeId=6e8916559e2df, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Circulation：ADCY9基因型对Anacetrapib临床疗效的影响, objectType=article, longId=179691, objectId=27ae1e9691de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27ae1e9691de, replyNumber=0, likeNumber=72, createdTime=2020-03-24, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27ae1e9691de, moduleTitle=Circulation：ADCY9基因型对Anacetrapib临床疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27ae1e9691de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655967, encodeId=ca92165596ef8, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACS Appl Mater Interfaces：含万古霉素和锶的微球可有效对抗骨感染并促进其再生, objectType=article, longId=178896, objectId=794c1e8896e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=794c1e8896e7, replyNumber=0, likeNumber=45, createdTime=2020-04-06, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=794c1e8896e7, moduleTitle=ACS Appl Mater Interfaces：含万古霉素和锶的微球可有效对抗骨感染并促进其再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=794c1e8896e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655946, encodeId=1b561655946f2, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=AACE2019：2型糖尿病可使老年女性短期骨折风险加倍, objectType=article, longId=165654, objectId=d83316565408, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d83316565408, replyNumber=0, likeNumber=85, createdTime=2019-06-22, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d83316565408, moduleTitle=AACE2019：2型糖尿病可使老年女性短期骨折风险加倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d83316565408)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655974, encodeId=7b0816559e46e, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Europace：中国房颤注册研究全新分析：房颤消融成功3个月后或可安全停用口服抗凝药, objectType=article, longId=180003, objectId=8fe018000347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fe018000347, replyNumber=0, likeNumber=76, createdTime=2020-05-01, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fe018000347, moduleTitle=Europace：中国房颤注册研究全新分析：房颤消融成功3个月后或可安全停用口服抗凝药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fe018000347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655990, encodeId=be651655990eb, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Stroke:首次卒中发作后，MACE风险显著增加, objectType=article, longId=188019, objectId=6eb5188019f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6eb5188019f1, replyNumber=0, likeNumber=62, createdTime=2020-10-02, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6eb5188019f1, moduleTitle=Stroke:首次卒中发作后，MACE风险显著增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6eb5188019f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655983, encodeId=953716559831d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据, objectType=article, longId=183160, objectId=386c183160e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=386c183160e6, replyNumber=0, likeNumber=77, createdTime=2020-03-30, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=386c183160e6, moduleTitle=2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=386c183160e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655950, encodeId=4c4c1655950ac, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=【2019 ASCO】聚焦中期肝细胞癌综合治疗，TACE的选择和优化, objectType=article, longId=167646, objectId=9fd616e64663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fd616e64663, replyNumber=0, likeNumber=18, createdTime=2019-08-25, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fd616e64663, moduleTitle=【2019 ASCO】聚焦中期肝细胞癌综合治疗，TACE的选择和优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fd616e64663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655996, encodeId=fd8816559964a, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Preprints:新冠肺炎两大易感因素：肥胖和癌症，缘于ACE2表达量更高, objectType=article, longId=188801, objectId=e27a18880152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27a18880152, replyNumber=0, likeNumber=72, createdTime=2020-06-21, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27a18880152, moduleTitle=Preprints:新冠肺炎两大易感因素：肥胖和癌症，缘于ACE2表达量更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27a18880152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655958, encodeId=5c84165595867, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Colloids Surf B Biointerfaces：复合水凝胶可有效抗菌促进伤口愈合, objectType=article, longId=168529, objectId=e54f1685292a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e54f1685292a, replyNumber=0, likeNumber=51, createdTime=2019-11-28, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e54f1685292a, moduleTitle=Colloids Surf B Biointerfaces：复合水凝胶可有效抗菌促进伤口愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e54f1685292a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655940, encodeId=e9ec1655940a1, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, objectType=article, longId=164907, objectId=fe4216490eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4216490eae, replyNumber=0, likeNumber=72, createdTime=2019-06-12, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4216490eae, moduleTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4216490eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655947, encodeId=900c165594e6e, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=J Colloid Interface Sci:石墨烯改良高性能橡胶复合材料, objectType=article, longId=165856, objectId=51731658560d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51731658560d, replyNumber=0, likeNumber=72, createdTime=2019-11-27, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51731658560d, moduleTitle=J Colloid Interface Sci:石墨烯改良高性能橡胶复合材料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51731658560d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655987, encodeId=9023165598e40, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=综述：ACE2的主要功能以及在新型冠状病毒中作用, objectType=article, longId=187281, objectId=507018e2810f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507018e2810f, replyNumber=0, likeNumber=151, createdTime=2020-09-28, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507018e2810f, moduleTitle=综述：ACE2的主要功能以及在新型冠状病毒中作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=507018e2810f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655951, encodeId=116316559510f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期, objectType=article, longId=167670, objectId=f89f16e6704f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f89f16e6704f, replyNumber=0, likeNumber=65, createdTime=2020-01-28, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f89f16e6704f, moduleTitle=ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f89f16e6704f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655956, encodeId=22bc165595662, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACS Appl Mater Interfaces：3D打印支架用于大块骨缺损的修复, objectType=article, longId=168498, objectId=3a1c168498c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a1c168498c8, replyNumber=0, likeNumber=66, createdTime=2019-07-05, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a1c168498c8, moduleTitle=ACS Appl Mater Interfaces：3D打印支架用于大块骨缺损的修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a1c168498c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655936, encodeId=37b41655936ff, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=ACS Appl Mater Interfaces：可互连动态压缩生物反应器用于三维细胞力学生物学组合筛选, objectType=article, longId=164774, objectId=2f93164e74e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f93164e74e6, replyNumber=0, likeNumber=43, createdTime=2020-02-18, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f93164e74e6, moduleTitle=ACS Appl Mater Interfaces：可互连动态压缩生物反应器用于三维细胞力学生物学组合筛选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f93164e74e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655948, encodeId=823816559483d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Colloids Surf B Biointerfaces：氧化石墨烯的尺寸大小可会影响细胞的增殖和分化, objectType=article, longId=166221, objectId=65fd166221d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65fd166221d5, replyNumber=0, likeNumber=71, createdTime=2020-01-13, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65fd166221d5, moduleTitle=Colloids Surf B Biointerfaces：氧化石墨烯的尺寸大小可会影响细胞的增殖和分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65fd166221d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655960, encodeId=55a4165596033, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, objectType=article, longId=168960, objectId=a861168960b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a861168960b7, replyNumber=0, likeNumber=71, createdTime=2020-02-01, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a861168960b7, moduleTitle=JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a861168960b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACE

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利

2020-04-23

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Pharmaceutics：西地那非体外溶解动力学揭示以用于新制剂的开发

2020-06-24

shanyongle (审核中...)

前往app查看评论内容

#ACE#

滕皋军教授：肝癌综合治疗新时代--TACE与系统治疗“强强联合”

2020-02-16

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Circulation：ADCY9基因型对Anacetrapib临床疗效的影响

2020-03-24

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACS Appl Mater Interfaces：含万古霉素和锶的微球可有效对抗骨感染并促进其再生

2020-04-06

智智灵药 (审核中...)

前往app查看评论内容

#ACE#

AACE2019：2型糖尿病可使老年女性短期骨折风险加倍

2019-06-22

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Europace：中国房颤注册研究全新分析：房颤消融成功3个月后或可安全停用口服抗凝药

2020-05-01

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Stroke:首次卒中发作后，MACE风险显著增加

2020-10-02

shanyongle (审核中...)

前往app查看评论内容

#ACE#

2019年美国心脏协会科学会议：Rilonacept治疗复发性心包炎的II期临床数据

2020-03-30

shanyongle (审核中...)

前往app查看评论内容

#ACE#

【2019 ASCO】聚焦中期肝细胞癌综合治疗，TACE的选择和优化

2019-08-25

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Preprints:新冠肺炎两大易感因素：肥胖和癌症，缘于ACE2表达量更高

2020-06-21

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Colloids Surf B Biointerfaces：复合水凝胶可有效抗菌促进伤口愈合

2019-11-28

智智灵药 (审核中...)

前往app查看评论内容

#ACE#

Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可

2019-06-12

智智灵药 (审核中...)

前往app查看评论内容

#ACE#

J Colloid Interface Sci:石墨烯改良高性能橡胶复合材料

2019-11-27

shanyongle (审核中...)

前往app查看评论内容

#ACE#

综述：ACE2的主要功能以及在新型冠状病毒中作用

2020-09-28

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期

2020-01-28

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACS Appl Mater Interfaces：3D打印支架用于大块骨缺损的修复

2019-07-05

shanyongle (审核中...)

前往app查看评论内容

#ACE#

ACS Appl Mater Interfaces：可互连动态压缩生物反应器用于三维细胞力学生物学组合筛选

2020-02-18

智智灵药 (审核中...)

前往app查看评论内容

#ACE#

Colloids Surf B Biointerfaces：氧化石墨烯的尺寸大小可会影响细胞的增殖和分化

2020-01-13

shanyongle (审核中...)

前往app查看评论内容

#ACE#

JACC：ACEI和β受体阻滞剂能减少化疗乳腺癌患者的心脏毒性

2020-02-01

科室
- - 订阅+
  - 更多科室
工具
服务